Loading...

Financial Statements

Apollo Endosurgery Inc.

Apollo Endosurgery Inc. (APEN)

Healthcare

Cash Flow Statement

Download APEN income statement Download APEN income statement
Year 2009201020112012201320142015201620172018
Depreciation & Amortization 0.180.170.140.190.200.228.069.099.729.29
Stock-based compensation 0.591.030.700.600.841.240.470.380.761.40
Operating Cash Flow -1.05-3.598.06-8.31-13.15-15.19-16.00-12.90-13.32-23.12
Capital Expenditure -0.57-0.47-0.49-0.34-0.39-0.54-4.76-1.03-1.56-1.95
Acquisitions and disposals -------0.140.20-10.00
Investment purchases and sales ----------
Investing Cash Flow ----------
Insurance (repayment) of debt ----------
Insurance (buybacks) of shares ----------
Dividend payments ----------
Financing Cash Flow 0.024.690.0318.870.7721.1533.4812.6226.709.70
Effect of forex changes on cash -------0.22-0.100.13-0.11
Net cash flow / Change in cash -1.600.637.6110.21-12.775.4310.34-2.5411.38-6.41
Free Cash Flow -1.62-4.057.57-8.66-13.54-15.72-20.77-13.93-14.88-25.07
Net Cash/Marketcap 0.000.000.000.000.000.00-0.00-0.00-0.000.00

Apollo Endosurgery Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Apollo Endosurgery Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.